Phosphatidylinositol 4-kinase


Function

Phosphatidylinositol 4-kinase (PI4K) modulates inter-organelle lipid tarfficking. phosphoinositide signalling and intracellular vescicle trafficking. The catalytic domain of PI4K is required for the synthesis of phosphatidylinositol 4-phosphate[1]. The mammalian PI4K are classified into 2 types - II and III - based on their molecular mass and modulation by detergent and adenosine.

  • Phosphatidylinositol 4-kinase IIα accounts for the bulk of PI4K activity in the brain and is concentrated at synapses[2].
  • Phosphatidylinositol 4-kinase IIβ synthesises phosphatidylinositok 4,5-bisphosphate at the plasma membrane[3].
  • Phosphatidylinositol 4-kinase IIIα catalyses the synthesis of phosphatidylinositol 4-phosphate in hepatitis C virus cells[4].
  • Phosphatidylinositol 4-kinase IIIβ is a key enzyme in the control of spingomyelin synthesis by controlling the flow of ceramide from the endoplasmic reticulum to the Golgi compartment[5].

Relevance

Phosphatidylinositol 4-kinase IIIβ is required for cellular entry by pseudoviruses bearing the SARS-CoV spike protein. Inhibitors of hPI4KIIIβ blocked the entry of SARS pseudoviruses into cells[6].

Structural highlights

The 3D structure of phosphatidylinositol 4-kinase IIIβ complex with an inhibitor shows the making various [7]. Based on superposition of this structure on others with PI4K bound to ATP it is evident that the inhibitor's 5-member ring overlap the adenine ring of ATP suggesting that this inhibitor functions by sterically blocking the binding of ATP to the enzyme.



Human phosphatidylinositol 4-kinase IIIβ complex with an inhibitor (PDB code 4wag)

Drag the structure with the mouse to rotate

3D structures of phosphatidylinositol 4-kinase3D structures of phosphatidylinositol 4-kinase

Updated on 21-July-2024

ReferencesReferences

  1. Clayton EL, Minogue S, Waugh MG. Mammalian phosphatidylinositol 4-kinases as modulators of membrane trafficking and lipid signaling networks. Prog Lipid Res. 2013 Jul;52(3):294-304. doi: 10.1016/j.plipres.2013.04.002. Epub , 2013 Apr 19. PMID:23608234 doi:http://dx.doi.org/10.1016/j.plipres.2013.04.002
  2. Guo J, Wenk MR, Pellegrini L, Onofri F, Benfenati F, De Camilli P. Phosphatidylinositol 4-kinase type IIalpha is responsible for the phosphatidylinositol 4-kinase activity associated with synaptic vesicles. Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3995-4000. doi:, 10.1073/pnas.0230488100. Epub 2003 Mar 19. PMID:12646710 doi:http://dx.doi.org/10.1073/pnas.0230488100
  3. Wei YJ, Sun HQ, Yamamoto M, Wlodarski P, Kunii K, Martinez M, Barylko B, Albanesi JP, Yin HL. Type II phosphatidylinositol 4-kinase beta is a cytosolic and peripheral membrane protein that is recruited to the plasma membrane and activated by Rac-GTP. J Biol Chem. 2002 Nov 29;277(48):46586-93. PMID:12324459 doi:10.1074/jbc.M206860200
  4. Reiss S, Harak C, Romero-Brey I, Radujkovic D, Klein R, Ruggieri A, Rebhan I, Bartenschlager R, Lohmann V. The lipid kinase phosphatidylinositol-4 kinase III alpha regulates the phosphorylation status of hepatitis C virus NS5A. PLoS Pathog. 2013 May;9(5):e1003359. PMID:23675303 doi:10.1371/journal.ppat.1003359
  5. Toth B, Balla A, Ma H, Knight ZA, Shokat KM, Balla T. Phosphatidylinositol 4-kinase IIIbeta regulates the transport of ceramide between the endoplasmic reticulum and Golgi. J Biol Chem. 2006 Nov 24;281(47):36369-77. doi: 10.1074/jbc.M604935200. Epub 2006, Sep 26. PMID:17003043 doi:http://dx.doi.org/10.1074/jbc.M604935200
  6. Yang N, Ma P, Lang J, Zhang Y, Deng J, Ju X, Zhang G, Jiang C. Phosphatidylinositol 4-kinase IIIbeta is required for severe acute respiratory syndrome coronavirus spike-mediated cell entry. J Biol Chem. 2012 Mar 9;287(11):8457-67. doi: 10.1074/jbc.M111.312561. Epub 2012 , Jan 17. PMID:22253445 doi:http://dx.doi.org/10.1074/jbc.M111.312561
  7. Mejdrova I, Chalupska D, Kogler M, Sala M, Plackova P, Baumlova A, Hrebabecky H, Prochazkova E, Dejmek M, Guillon R, Strunin D, Weber J, Lee G, Birkus G, Mertlikova-Kaiserova H, Boura E, Nencka R. Highly Selective Phosphatidylinositol 4-Kinase IIIbeta Inhibitors and Structural Insight into Their Mode of Action. J Med Chem. 2015 May 14;58(9):3767-93. doi: 10.1021/acs.jmedchem.5b00499. Epub, 2015 May 4. PMID:25897704 doi:http://dx.doi.org/10.1021/acs.jmedchem.5b00499

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Alexander Berchansky